Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-03A Phase 3, Randomized, Observer-blind, Placebo-controlled Study to Evaluate the Immunogenicity, Safety, and Reactogenicity of mRNA-1018-H5 Pandemic Influenza Vaccine in Adults ≥18 Years of Age
-
CLINICAL_TRIALS study record update · 2026-04-03A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Patients With Influenza and Transmission of Influenza to Household Contacts
-
CLINICAL_TRIALS study record update · 2026-04-01Post-Exposure Influenza Chemoprophylaxis With Oseltamivir for Five Days vs Ten Days in Acute-Care Hospital: a Non-Inferiority Randomized Open-Label Study
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase 2a, Single-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tivoxavir Marboxil (TRX-100) in Healthy Adults in a Human Influenza A Challenge Model
-
CLINICAL_TRIALS study record update · 2026-03-31Patient-Reported Outcomes Associated With COVID-19 and Influenza: A Prospective Survey Study on Outpatient Symptomatic Adults With Test-Confirmed Illness in the United States
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-30Revealing Protective Immunity to Influenza Using Systems Immunology
-
CLINICAL_TRIALS study record update · 2026-03-27A Multicenter, Open-Label, Randomized Phase 2a Study to Evaluate the Safety and Efficacy of Different Oral Doses of TRX-100 and Standard of Care in Participants With Influenza
-
CLINICAL_TRIALS study record update · 2026-03-27Influenza Human Challenge Model
-
CLINICAL_TRIALS study record update · 2026-03-24Comparison of Immunogenicity of Different Influenza Vaccines in Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-03-23Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting
-
CLINICAL_TRIALS study record update · 2026-03-19Clinical Trial of H1ssF Vaccine vs. Seasonal Influenza Vaccine in Previously Unvaccinated Adults and Previously Vaccinated Adults
-
CLINICAL_TRIALS study record update · 2026-03-18Clinical Performance Evaluation of the VitaSIRO Solo™ SARS-CoV-2/Flu/RSV Assay
-
CLINICAL_TRIALS study record update · 2026-03-16Influenza Immunization in Adults Over Age 75
-
CLINICAL_TRIALS study record update · 2026-03-13A Randomized, Observer-Blind, Adaptive, Active Comparator-Controlled, Dose-Ranging, Multicenter, Safety, Tolerability, and Immunogenicity Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine in Adults 18 Years of Age and Older
-
CLINICAL_TRIALS study record update · 2026-03-12Dissecting Human Immune Responses To Infection With Influenza or SARS-CoV-2
-
CLINICAL_TRIALS study record update · 2026-03-12A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of IDP® Supplement on Respiratory Immune Health Outcomes During Cold and Flu Season in Older Individuals
-
CLINICAL_TRIALS study record update · 2026-03-10The Immunogenicity and Safety of COVID-19 and Influenza Vaccine Co-administration and Interval in Immunocompromised Hosts
-
CLINICAL_TRIALS study record update · 2026-03-06Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
-
CLINICAL_TRIALS study record update · 2026-03-04Application of Myxovirus Resistance Protein A in Antiviral Treatment Guidance of Respiratory Viral Infections
-
CLINICAL_TRIALS study record update · 2026-03-04Impact of High Dietary Fiber on Microbiome and Vaccine Responses
-
CLINICAL_TRIALS study record update · 2026-03-03Influenza Human Challenge Model Using H3N2 (A/Texas/71/2017 (H3N2), Clade 3C3a)
-
CLINICAL_TRIALS study record update · 2026-03-02Dime La VerDAD: Verify, Debunk, and Disseminate
-
CLINICAL_TRIALS study record update · 2026-02-27Delineating Gut Microbiome and Dietary Determinants Associated With Favorable Vaccine Response
-
CLINICAL_TRIALS study record update · 2026-02-23A PHASE 1, RANDOMIZED, OBSERVER-BLIND, DOSE-RANGING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST PANDEMIC INFLUENZA IN HEALTHY ADULTS
-
CLINICAL_TRIALS study record update · 2026-02-23A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CD388, a Novel Long-Acting Antiviral Conjugate, for the Prevention of Influenza in Adults and Adolescents at Higher Risk of Developing Influenza Complications